Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE is a generic product labeled by Lannett Company Inc., priced at $0.3355 per EA under NDC 00527409537. Its NADAC has been published 330 times since Mar 4, 2020.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE
Butalbital, Acetaminophen, and Caffeine CapsulesStrength
300; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Lannett Company Inc.NDC
00527409537
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA212082On Market Since
12/17/2019
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has been published 330 times since Mar 4, 2020, and over the history we have for it it has declined 79.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3355 per EA |
|---|---|
| All-time high | $1.6582 (Apr 15, 2020) |
| All-time low | $0.3110 (Apr 22, 2026) |
| 52-week high | $0.4542 |
| 52-week low | $0.3110 |
| Median price | $0.5983 |
| Average price | $0.6538 |
| Largest weekly change | +34.5% (Jun 19, 2024) |
| Weeks tracked | 330 |
| Tracking since | Mar 4, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Butalbital, Acetaminophen, and Caffeine Capsules market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, manufactured by Lannett Company Inc., is $0.3355 per EA (NDC 00527409537), effective Jun 24, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has declined 79.4%. It has been tracked across 330 weekly CMS publications since Mar 4, 2020.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
Since Mar 4, 2020, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has ranged from a low of $0.3110 (Apr 22, 2026) to a high of $1.6582 (Apr 15, 2020), with a median of $0.5983 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE (NDC 00527409537) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification